Fredrik Strand
Founder

ClearScanAI provides an AI-powered risk assessment tool, AISmartDensity®, that analyzes mammograms to identify patients at higher risk of missed breast cancer. This deep learning technology evaluates cancer likelihood, long-term risk, and tissue masking potential to guide supplemental screening decisions. The platform aims to enhance breast cancer detection programs by accurately targeting individuals who would benefit most from additional imaging like MRI.
Funding not disclosed
across 1 round
Founder